Malathi, D. C., Janakiraman, K., Thangavelu, S. V. A. and Ravichandran, D. (2026) “Enlicitide (Lipfendra): the first oral PCSK9 inhibitor - from macrocyclic peptide innovation to clinical translation”, International Journal of Basic & Clinical Pharmacology, 15(5), pp. 1126–1134. doi: 10.18203/2319-2003.ijbcp20262890.